. . . . . . . . . "alogliptin tablets are a dipeptidyl peptidase 4 dpp 4 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus 1 1 14 important limitations of use not for treatment of type 1 diabetes or diabetic ketoacidosis 1 1 alogliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies 14 important limitations of use alogliptin tablets are not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis as it would not be effective in these settings" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "WtbHR3i+5ydBrvRDiyxAg3dRVyLz6Bt2rKWzY2rycP2eKJadAPvbDJI484YUJBidj0oCS9C6v3LKwDha7DQip8yHPJ+CymRhKWBmr9spZF0Rxf+sk6SFIrGPr9Z1AxF35dXKoIOYhfMKoZvZfuMBKe4aFmRPIrBm8djFDL7f4Os=" . . "2021-06-12T14:43:14.540+02:00"^^ . . . . .